G-protein-coupled receptors (GPCRs) represent the largest known family of signal-transducing molecules, and convey signals for light and many extracellular regulatory molecules. GPCRs are dysfunctional or dysregulated in several human diseases and are estimated to be the targets of O40% of the drugs used in clinical medicine today. The crystal structure of rhodopsin provides the first information on the three-dimensional structure of GPCRs, which now supports homology modeling studies and structure-based drug-design approaches.
Tecniques: recent developments in computer aided engineering of GPCR ligands using the human A3 adenosine receptor as an example / Stefano, Moro; Spalluto, Giampiero; KENNETH A., Jacobson. - In: TRENDS IN PHARMACOLOGICAL SCIENCES. - ISSN 0165-6147. - STAMPA. - 26:(2005), pp. 44-51. [10.1016/j.tips.2004.11.006]
Tecniques: recent developments in computer aided engineering of GPCR ligands using the human A3 adenosine receptor as an example.
SPALLUTO, GIAMPIERO;
2005-01-01
Abstract
G-protein-coupled receptors (GPCRs) represent the largest known family of signal-transducing molecules, and convey signals for light and many extracellular regulatory molecules. GPCRs are dysfunctional or dysregulated in several human diseases and are estimated to be the targets of O40% of the drugs used in clinical medicine today. The crystal structure of rhodopsin provides the first information on the three-dimensional structure of GPCRs, which now supports homology modeling studies and structure-based drug-design approaches.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


